Microbix Biosystems (TSE:MBX) Stock Price Passes Above 50 Day Moving Average – Time to Sell?

Microbix Biosystems Inc. (TSE:MBX) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$0.23 and traded as high as C$0.25. Microbix Biosystems shares last traded at C$0.23, with a volume of 35,150 shares.

Microbix Biosystems Price Performance

The company has a current ratio of 7.15, a quick ratio of 5.57 and a debt-to-equity ratio of 22.61. The company has a 50 day moving average of C$0.23 and a 200-day moving average of C$0.24. The firm has a market capitalization of C$31.93 million, a P/E ratio of -14.38 and a beta of 0.15.

Microbix Biosystems (TSE:MBX) last posted its quarterly earnings data on Thursday, February 12th. The company reported C($0.01) earnings per share for the quarter. The firm had revenue of C$4.22 million for the quarter. Microbix Biosystems had a return on equity of 12.65% and a net margin of 13.86%. On average, sell-side analysts predict that Microbix Biosystems Inc. will post 0.02 EPS for the current year.

Microbix Biosystems Company Profile

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.